IGHMBP2 and Charcot-Marie-Tooth disease axonal type 2S: Previous studies showed that IGHMBP2 mRNA levels were preserved in SMARD1/CMT2S patients despite the reduction of protein levels in both phenotypes compared with healthy individuals, and in SMARD1 subjects, the protein level was lower than that in CMT2S patients (3, 4, 18).